Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan

Fig. 2

Changes in clinical indicators pre and post Mepolizumab initiation in GC-free and GC-continue patients. P values were determined by Wilcoxon signed-rank test. P < 0.05: pre-MPZ vs post-MPZ, GC-free vs. GC-continue at each indicator. MPZ mepolizumab, PSL prednisolone, BVAS Birmingham Vasculitis Activity Score, VDI Vascular Damage Index

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us